%PDF-1.4
%
4 0 obj
<>
endobj
5 0 obj
<>stream
Hou X.; Hossini A.M.; Nikolakis G.; Balthasar O.; Kurtz A.; Zouboulis C.C.
3D-SeboSkin Model for Human ex vivo Studies of Hidradenitis Suppurativa/Acne Inversa
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.<br />
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.<br />
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
Background: Hidradenitis suppurativa/acne inversa (HS) is a chronic, recurrent inflammatory skin disease. Its pivotal pathogenetic event is believed to be the occlusion of the hair follicle generating a perifollicular lympho-histiocytic inflammation. However, knowledge of the exact HS pathogenesis requires further research. Objective: To develop a human HS model applicable in preclinical research which could help to understand the pathophysiology of HS and to determine the action of therapeutic candidates. Methods: The 3D-SeboSkin technology was applied to maintain explants of involved and uninvolved skin of HS patients ex vivo for 3 days. Detection of differential expression of previously detected HS biomarkers was performed by immunohistochemistry in a group of female patients (n = 9, mean age 37.2 ± 8.4 years). Results: The application of the 3D-SeboSkin model preserved the structural integrity of lesional and perilesional HS skin ex vivo, as previously described for healthy skin. Moreover, the HS 3D-SeboSkin setting maintained the differential expression and pattern of several HS biomarkers (S100A9, KRT16, SERPINB3) in epidermal and dermal tissue and the appendages. Conclusion: We have validated HS 3D-SeboSkin as a reproducible, human model, which is appropriate for preclinical lesional and perilesional HS skin studies ex vivo.
Hidradenitis suppurativa
Skin model
Ex vivo
3D-SeboSkin
endstream
endobj
6 0 obj
<>stream
x+ |
endstream
endobj
7 0 obj
<>stream
x}
0EYi&1Meե`![F(n) r{yHʎ0q%ɴg3*A9Bx*d^->}fbN#1ǝ4b\gGզw@f\er90JPCB8
2mI>s>
endstream
endobj
8 0 obj
<>stream
x+ |
endstream
endobj
9 0 obj
<>stream
x}
0EYi21Meե`![F(n) r{yHeGd33*As kKT
'E{mvW5Fb͏;g'iŸMaﶁ̸6e1E9x"(W*AG3y"CLLmI>_>
endstream
endobj
10 0 obj
<>stream
x+ |
endstream
endobj
11 0 obj
<>stream
x}
@wYqui&hk8ل4JQۦ sp>8<&ܙq5ʕg",@}s
)ZK'ewMWV-:}fc>ҙ lhכ1Xȵk/K0S)xt&!CFq
Jb K?
endstream
endobj
12 0 obj
<>stream
x+ |
endstream
endobj
13 0 obj
<>stream
x}
0<uhJc)Eu-lȹ\8
toCB|r9
%
T("ɢݕ->}f%w lw):ȍ/K0S%Q98ʘƀe\dzöԨ
7?
endstream
endobj
14 0 obj
<>stream
x+ |
endstream
endobj
15 0 obj
<>stream
x}
0<uhӤJc)Eu-lȹ\8
toCB|rX
3,@}s
) JD E{uu+M [S})>ǝ"8{1Sڻu_[_0S)dp&1#˸mQ1#?
endstream
endobj
16 0 obj
<>stream
x+ |
endstream
endobj
17 0 obj
<>stream
x}
0EYi&1}-.VkM-~¦A9edPv-IaA%#37&\*Kff&/t{su*Eb-OykxϾuaBr90CICA9319x"d"kw?[
endstream
endobj
18 0 obj
<>stream
x+ |
endstream
endobj
19 0 obj
<>stream
x}
0EYii,Dp[i6Ŵ(nRAs{ Gpo(C>stream
x+ |
endstream
endobj
21 0 obj
<>stream
x}
0EYiMvYu)XVi6Ŵ(nRAs{@pghUx\r5",@RG5O |2[7[Rpg0WORp̧wA [ku]K0rjc$)T
,9f4IHƀe\dföRxsS?c
endstream
endobj
24 0 obj
<>stream
HWr6}W%U}ymgL+3e?5$8\h~$ՋD
9wzp٩s/]ݗG?{%-<2'(c%,v SX w9`Nvjjz,kvGUU2DO jټOl%^W9OA7nPVt9VcեnKu(e?H_3+^/=%kY1ȣy30q